IGF1R and rhabdomyosarcoma: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in combination with the Src family kinase (SFK) inhibitor dasatinib in people with Embryonal and Alveolar Rhabdomyosarcoma